Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03772275
Recruitment Status : Recruiting
First Posted : December 11, 2018
Last Update Posted : December 11, 2018
Sponsor:
Information provided by (Responsible Party):
Sherief Abd-Elsalam, Tanta University

Brief Summary:
Clinical and Economic study of some new biomarkers in chronic heart failure.

Condition or disease Intervention/treatment Phase
Heart Failure Diagnostic Test: New york Heart Association Class II-IV Diagnostic Test: New york Heart Association Class I Not Applicable

Detailed Description:
The study aimed at evaluation of the clinical and economic value of some new biomarkers in chronic heart failure.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Clinical and Economical Study Evaluating the Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure
Actual Study Start Date : October 1, 2018
Estimated Primary Completion Date : October 2026
Estimated Study Completion Date : October 2027

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure

Arm Intervention/treatment
Active Comparator: New york Heart Association Class II-IV
New york Heart Association Class II-IV heart failure
Diagnostic Test: New york Heart Association Class II-IV
New york Heart Association Class II-IV " study of markers"
Other Name: Severe heart failure

Active Comparator: New york Heart Association Class I
New york Heart Association Class I with no heart failure
Diagnostic Test: New york Heart Association Class I
New york Heart Association Class I
Other Name: No heart failure




Primary Outcome Measures :
  1. Number of participants with elevated markers (IL17) [ Time Frame: 6 months ]
    Number of participants with elevated markers (IL17)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • NYHA-Class II-IV

Exclusion Criteria:

  • Liver or renal dysfunction. --DM

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03772275


Contacts
Layout table for location contacts
Contact: Sherief Abd-Elsalam, Ph D 00201147773440 sheriefabdelsalam@yahoo.com

Locations
Layout table for location information
Egypt
Sherief Abd-Elsalam Recruiting
Tanta, Elgharbia, Egypt, 35111
Contact: Nermin W Ishak, Msc         
Sponsors and Collaborators
Sherief Abd-Elsalam
Investigators
Layout table for investigator information
Principal Investigator: Osama M Ibrahim, Prof Prof of Clinical Pharmacy
Study Director: Medhat M Eshmawy, Prof Cardiology Department- Tanta University
Study Chair: Nermin W Ishaq, Msc Clinical pharmacy Department- Tanta University
Layout table for additonal information
Responsible Party: Sherief Abd-Elsalam, Ass. Prof. Tropical Medicine, Tanta University
ClinicalTrials.gov Identifier: NCT03772275    
Other Study ID Numbers: Heart failure
First Posted: December 11, 2018    Key Record Dates
Last Update Posted: December 11, 2018
Last Verified: December 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases